RemedyRepack Inc. is recalling 247 blister packs of Carvedilol (25 mg tablets), a prescription medication used to treat heart failure and high blood pressure. The recall was issued because the tablets contain an impurity called N-Nitroso Carvedilol Impurity-1 (NNC 1) at levels that exceed the acceptable intake limits recommended by the FDA. Consumers using this medication should speak with their doctor or pharmacist before stopping their treatment, as the risk of suddenly stopping the drug may be higher than the risk of exposure to the impurity.
The tablets contain N-Nitroso Carvedilol, which is a type of nitrosamine impurity. Nitrosamines are classified as probable human carcinogens, meaning long-term exposure above recommended levels may increase the risk of developing cancer.
You have 2 options:
Manufactured by Glenmark; Repackaged by RemedyRepack Inc.; Recall #: D-0217-2025
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.